AU Patent

AU528310B2 — Composition of paracetamol and metoclopramide

Assigned to Beecham Group PLC · Expires 1983-04-21 · 43y expired

What this patent protects

Effervescent analgesic powders which comprise paracetamol D.C., and metoclopramide or an acid addition salt thereof, the weight ratio of paracetamol D.C. to metoclopramide or the acid addition salt thereof lying in the range 50:1 to 250:1, and a process for their preparation.

USPTO Abstract

Effervescent analgesic powders which comprise paracetamol D.C., and metoclopramide or an acid addition salt thereof, the weight ratio of paracetamol D.C. to metoclopramide or the acid addition salt thereof lying in the range 50:1 to 250:1, and a process for their preparation.

Drugs covered by this patent

Reglan (Metoclopramide Hydrochloride) · Hikma

Patent Metadata

Patent number: AU528310B2
Jurisdiction: AU
Classification: —
Expires: 1983-04-21
Drug substance claim: No
Drug product claim: No
Assignee: Beecham Group PLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.